Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypertension

  Free Subscription


15.08.2022

1 Am Heart J
1 Am J Cardiol
1 Am J Hypertens
2 Circulation
6 Eur Heart J
1 Eur J Pharmacol
13 Hypertension
2 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 J Diabetes Complications
3 J Hum Hypertens
21 J Hypertens
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. WANG SY, Hanna JM, Gongal P, Onuma O, et al
    Choice of Antihypertensive Agent in Isolated Systolic Hypertension and Isolated Diastolic Hypertension: A Secondary Analysis of the ALLHAT Trial.
    Am Heart J. 2022 Aug 3. pii: S0002-8703(22)00157.
    PubMed         Abstract available


    Am J Cardiol

  2. KIM M, Cho MS, Nam GB, Do U, et al
    Controlled Level and Variability of Systolic Blood Pressure on the Risk of Thromboembolic Events in Atrial Fibrillation and Hypertension.
    Am J Cardiol. 2022 Aug 4. pii: S0002-9149(22)00703.
    PubMed         Abstract available


    Am J Hypertens

  3. RIZZONI D, Agabiti Rosei C, De Ciuceis C
    State Of The Art Review: Vascular Remodeling In Hypertension.
    Am J Hypertens. 2022 Aug 12. pii: 6663929. doi: 10.1093.
    PubMed         Abstract available


    Circulation

  4. WHELTON PK, Carey RM, Mancia G, Kreutz R, et al
    Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations.
    Circulation. 2022 Aug 11:101161CIRCULATIONAHA121054602.
    PubMed         Abstract available

  5. WELLS CE, Cunningham FG
    Treatment of Chronic Hypertension in Pregnancy: Is It Time for a Change?
    Circulation. 2022;146:433-434.
    PubMed        


    Eur Heart J

  6. LOPEZ-JARAMILLO P, Joseph P, Lopez-Lopez JP, Lanas F, et al
    Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy.
    Eur Heart J. 2022;43:2841-2851.
    PubMed         Abstract available

  7. PRESCOTT E
    Lessons from PURE on modifiable risk.
    Eur Heart J. 2022;43:2864-2866.
    PubMed        

  8. LI S, Liu Z, Joseph P, Hu B, et al
    Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy.
    Eur Heart J. 2022;43:2852-2863.
    PubMed         Abstract available

  9. JOSEPH P, Kutty VR, Mohan V, Kumar R, et al
    Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy.
    Eur Heart J. 2022;43:2831-2840.
    PubMed         Abstract available

  10. WOUDA RD, Boekholdt SM, Khaw KT, Wareham NJ, et al
    Sex-specific associations between potassium intake, blood pressure, and cardiovascular outcomes: the EPIC-Norfolk study.
    Eur Heart J. 2022;43:2867-2875.
    PubMed         Abstract available

  11. UMEI TC, Kishino Y, Kawakami T, Fukuda K, et al
    Recurrent pulmonary thrombosis after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2022 Aug 8. pii: 6658235. doi: 10.1093.
    PubMed        


    Eur J Pharmacol

  12. TURHAN K, Alan E, Yetik-Anacak G, Sevin G, et al
    H2S releasing sodium sulfide protects against pulmonary hypertension by improving vascular responses in monocrotaline-induced pulmonary hypertension.
    Eur J Pharmacol. 2022 Aug 5:175182. doi: 10.1016/j.ejphar.2022.175182.
    PubMed         Abstract available


    Hypertension

  13. MUNTNER P, Miles MA, Jaeger BC, Hannon Iii L, et al
    Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020.
    Hypertension. 2022;79:1971-1980.
    PubMed         Abstract available

  14. SANGA V, Rossitto G, Seccia TM, Rossi GP, et al
    Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review.
    Hypertension. 2022;79:1912-1921.
    PubMed         Abstract available

  15. HALEY JE, Woodly SA, Daniels SR, Falkner B, et al
    Association of Blood Pressure-Related Increase in Vascular Stiffness on Other Measures of Target Organ Damage in Youth.
    Hypertension. 2022;79:2042-2050.
    PubMed         Abstract available

  16. CUSHMAN WC, Ringer RJ, Rodriguez CJ, Evans GW, et al
    Blood Pressure Intervention and Control in SPRINT.
    Hypertension. 2022;79:2071-2080.
    PubMed         Abstract available

  17. NARITA K, Hoshide S, Kario K
    Seasonal Variation in Day-by-Day Home Blood Pressure Variability and Effect on Cardiovascular Disease Incidence.
    Hypertension. 2022 Jun 30:101161HYPERTENSIONAHA12219494.
    PubMed         Abstract available

  18. KIVIOJA A, Toivonen E, Tyrmi J, Ruotsalainen S, et al
    Increased Risk of Preeclampsia in Women With a Genetic Predisposition to Elevated Blood Pressure.
    Hypertension. 2022;79:2008-2015.
    PubMed         Abstract available

  19. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
    Systolic Blood Pressure and Effects of Screening for Atrial Fibrillation With Long-Term Continuous Monitoring (a LOOP Substudy).
    Hypertension. 2022;79:2081-2090.
    PubMed         Abstract available

  20. WANG X, Jiang S, Fei L, Dong F, et al
    Tacrolimus Causes Hypertension by Increasing Vascular Contractility via RhoA (Ras Homolog Family Member A)/ROCK (Rho-Associated Protein Kinase) Pathway in Mice.
    Hypertension. 2022 Aug 8:101161HYPERTENSIONAHA12219189.
    PubMed         Abstract available

  21. EGAN BM
    Hypertension Control Among US Adults, 2009 to 2012 Through 2017 to 2020, and the Impact of COVID-19.
    Hypertension. 2022;79:1981-1983.
    PubMed        


  22. Correction to: Association Between Hypertension and Incident Infective Endocarditis.
    Hypertension. 2022;79:e114.
    PubMed        

  23. SAHA P, Mell B, Golonka RM, Bovilla VR, et al
    Selective IgA Deficiency in Spontaneously Hypertensive Rats With Gut Dysbiosis.
    Hypertension. 2022 Aug 11:101161HYPERTENSIONAHA12219307.
    PubMed         Abstract available

  24. LI G, Xu K, Xing W, Yang H, et al
    Swimming Exercise Alleviates Endothelial Mitochondrial Fragmentation via Inhibiting Drp1 (Dynamin-Related Protein-1) to Improve Vascular Function in Hypertension.
    Hypertension. 2022 Aug 11:101161HYPERTENSIONAHA12219126.
    PubMed         Abstract available

  25. GROENLAND EH, Vendeville JAC, Bemelmans RHH, Monajemi H, et al
    Smartphone Application-Assisted Home Blood Pressure Monitoring Compared With Office and Ambulatory Blood Pressure Monitoring in Patients With Hypertension: the AMUSE-BP Study.
    Hypertension. 2022 Aug 12:101161HYPERTENSIONAHA12219685.
    PubMed         Abstract available


    J Am Coll Cardiol

  26. WILKINS MR
    Pulmonary Hypertension: Dissecting a Complex Phenotype.
    J Am Coll Cardiol. 2022;80:719-721.
    PubMed        

  27. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
    Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
    J Am Coll Cardiol. 2022;80:565-578.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  28. D'SOUZA MS, Luu AN, Guisinger TC, Seeley SL, et al
    Regulator of G-Protein Signaling 5 Protein Deficiency Differentially Influences Blood Pressure, Vascular and Behavioral Effects in Aged Male Mice.
    J Cardiovasc Pharmacol. 2022;80:305-313.
    PubMed         Abstract available


    J Diabetes Complications

  29. HAN E, Kim MK, Im SS, Jang BK, et al
    Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity.
    J Diabetes Complications. 2022;36:108253.
    PubMed         Abstract available


    J Hum Hypertens

  30. WELLER RB, Macintyre IM, Melville V, Farrugia M, et al
    The effect of daily UVA phototherapy for 2 weeks on clinic and 24-h blood pressure in individuals with mild hypertension.
    J Hum Hypertens. 2022 Aug 5. pii: 10.1038/s41371-022-00729.
    PubMed         Abstract available

  31. HASELER E, Singh C, Newton J, Melhem N, et al
    Demographics of childhood hypertension in the UK: a report from the Southeast England.
    J Hum Hypertens. 2022 Aug 6. pii: 10.1038/s41371-022-00732.
    PubMed         Abstract available

  32. KAUR P, Kunwar A, Sharma M, Durgad K, et al
    The India Hypertension Control Initiative-early outcomes in 26 districts across five states of India, 2018-2020.
    J Hum Hypertens. 2022 Aug 9. pii: 10.1038/s41371-022-00742.
    PubMed         Abstract available


    J Hypertens

  33. BOGAERTS JMK, Poortvliet RKE, van der Klei VMGTH, Achterberg WP, et al
    Disentangling the varying associations between systolic blood pressure and health outcomes in the very old: an individual patient data meta-analysis.
    J Hypertens. 2022;40:1786-1794.
    PubMed         Abstract available

  34. LEE EK, Zhu M, Chan DC, Yip BH, et al
    Comparing effect of definition of diurnal periods by diary, fixed periods, and actigraphy on ambulatory blood pressure parameters in a Chinese population.
    J Hypertens. 2022;40:1815-1821.
    PubMed         Abstract available

  35. NAKAGAWA K, Chen R, Greenberg SM, Ross GW, et al
    Forkhead box O3 longevity genotype may attenuate the impact of hypertension on risk of intracerebral haemorrhage.
    J Hypertens. 2022 Aug 4. pii: 00004872-990000000-00061.
    PubMed         Abstract available

  36. JIN X, Narisawa M, Piao L, Cheng XW, et al
    Protein tyrosine phosphatase receptor type D as a potential therapeutic target in pulmonary artery hypertension.
    J Hypertens. 2022;40:1650-1654.
    PubMed        

  37. HITIJ JB
    Association of depressive symptoms and hypertension prevalence, awareness, treatment.
    J Hypertens. 2022;40:1655-1657.
    PubMed        

  38. LAU D, Ringrose J, McAlister FA, Fradette M, et al
    Telemonitoring and protocolized case management for hypertensive community dwelling older adults (TECHNOMED): a randomized controlled trial.
    J Hypertens. 2022;40:1702-1712.
    PubMed         Abstract available

  39. LIU MM, Peng J, Xu RX, Guo YL, et al
    Hypertension and clinical outcomes in patients with familial hypercholesterolemia.
    J Hypertens. 2022;40:1713-1721.
    PubMed         Abstract available

  40. CHAMBERS LC, Diaz-Otero JM, Fisher CL, Jackson WF, et al
    Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertension.
    J Hypertens. 2022;40:1722-1734.
    PubMed         Abstract available

  41. QU Y, Guo ZN, Zhang P, Ma HY, et al
    Time course of beat-to-beat blood pressure variability and outcome in patients with spontaneous intracerebral haemorrhage.
    J Hypertens. 2022;40:1744-1750.
    PubMed         Abstract available

  42. LIU Y, Zhong C, Si J, Chen S, et al
    The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive rats.
    J Hypertens. 2022;40:1822-1830.
    PubMed         Abstract available

  43. CALO LA, Stefanelli LF, Bertoldi G, Ravarotto V, et al
    Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more.
    J Hypertens. 2022;40:1836-1837.
    PubMed        

  44. LI C, Wang Q, Qing Y, Ma L, et al
    Rho kinase inhibition on renal remodeling in an apatinib-induced hypertensive rat model.
    J Hypertens. 2022;40:1838-1840.
    PubMed        


  45. Hyperuricemia and risk of hypertension resistant to therapy: a systematic review and meta-analysis: Erratum.
    J Hypertens. 2022;40:1845.
    PubMed        

  46. FANG X, Ma L, Wang Y, Ren F, et al
    Neutrophil extracellular traps accelerate vascular smooth muscle cell proliferation via Akt/CDKN1b/TK1 accompanying with the occurrence of hypertension.
    J Hypertens. 2022 Aug 4. pii: 00004872-990000000-00062.
    PubMed         Abstract available

  47. FALLO F, Di Dalmazi G, Beuschlein F, Biermasz NR, et al
    Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00081.
    PubMed         Abstract available

  48. KANG MY
    Occupational risk factors for hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00074.
    PubMed         Abstract available

  49. LI J, Tong D, Song B, Xie F, et al
    Inflammatory cytokines induce neutrophil extracellular traps interaction with activated platelets and endothelial cells exacerbate coagulation in moderate and severe essential hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00070.
    PubMed         Abstract available

  50. ZHENG X, Han L, Shen S
    Hypertension, remnant cholesterol and cardiovascular disease: evidence from the China health and retirement longitudinal study.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00079.
    PubMed         Abstract available

  51. IATRIDI F, Theodorakopoulou MP, Papagianni A, Sarafidis P, et al
    Management of intradialytic hypertension: current evidence and future perspectives.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00071.
    PubMed         Abstract available

  52. KABIA AU, Li P, Jin Z, Tan X, et al
    The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00080.
    PubMed         Abstract available

  53. VELDHUIZEN GP, Alnazer RM, Kroon AA, de Leeuw PW, et al
    Variability of aldosterone, renin and the aldosterone-to-renin ratio in hypertensive patients without primary aldosteronism.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00078.
    PubMed         Abstract available


    PLoS One

  54. BASENERO A, Neidel J, Ikeda DJ, Ashivudhi H, et al
    Integrating hypertension and HIV care in Namibia: A quality improvement collaborative approach.
    PLoS One. 2022;17:e0272727.
    PubMed         Abstract available

  55. KGANAKGA JT, Bester P, Ricci C, Botha-Le Roux S, et al
    Prognostic values of modifiable risk factors for cardiovascular events in South African health promotion.
    PLoS One. 2022;17:e0271169.
    PubMed         Abstract available

  56. TAJEU GS, Colvin CL, Hardy ST, Bress AP, et al
    Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study.
    PLoS One. 2022;17:e0270675.
    PubMed         Abstract available

  57. MANOSROI W, Tacharearnmuang N, Atthakomol P
    Clinical and biochemical predictors and predictive model of primary aldosteronism.
    PLoS One. 2022;17:e0272049.
    PubMed         Abstract available

  58. MEKIE M, Bezie M, Melkie A, Addisu D, et al
    Perception towards preeclampsia and perceived barriers to early health-seeking among pregnant women in selected Hospitals of South Gondar Zone, Northwest Ethiopia: A qualitative study.
    PLoS One. 2022;17:e0271502.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: